Effect of novel glucose lowering agents on non-alcoholic fatty liver disease: A systematic review and meta-analysis
{{output}}
Background: The efficacy of novel glucose-lowering drugs in treating non-alcoholic fatty liver disease (NAFLD) in patients with and without type-2 diabetic patients (T2DM) remains unclear. ... ...
